0001562180-22-000352.txt : 20220107
0001562180-22-000352.hdr.sgml : 20220107
20220107211711
ACCESSION NUMBER: 0001562180-22-000352
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220106
FILED AS OF DATE: 20220107
DATE AS OF CHANGE: 20220107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stock Elyse
CENTRAL INDEX KEY: 0001785732
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 22519447
BUSINESS ADDRESS:
BUSINESS PHONE: (203) 404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-01-06
false
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001785732
Stock Elyse
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN
CT
06510
false
true
false
false
Chief Medical Officer
Common Shares
2022-01-06
4
M
false
3750.00
0.00
A
11217.00
D
Common Shares
2022-01-06
4
F
false
1838.00
123.86
D
9379.00
D
Common Shares
2022-01-06
4
M
false
1250.00
0.00
A
3437.00
I
By Spouse
Common Shares
2022-01-07
4
M
false
3250.00
0.00
A
12629.00
D
Common Shares
2022-01-07
4
F
false
1539.00
128.87
D
11090.00
D
Common Shares
2022-01-07
4
M
false
1000.00
0.00
A
4437.00
I
By Spouse
Restricted Share Unit Award
2022-01-06
4
M
false
3750.00
0.00
D
Common Shares
3750.00
7500.00
D
Restricted Share Unit Award
2022-01-06
4
M
false
1250.00
0.00
D
Common Shares
1250.00
2500.00
I
By Spouse
Employee Stock Option (right to buy)
128.87
2022-01-07
4
M
false
26000.00
0.00
A
2032-01-07
Common Shares
26000.00
26000.00
D
Restricted Share Unit Award
2022-01-07
4
A
false
13000.00
0.00
A
Common Shares
13000.00
13000.00
D
Restricted Share Unit Award
2022-01-07
4
M
false
3250.00
0.00
D
Common Shares
3250.00
9750.00
D
Restricted Share Unit Award
2022-01-07
4
A
false
4000.00
0.00
A
Common Shares
4000.00
4000.00
I
By Spouse
Restricted Share Unit Award
2022-01-07
4
M
false
1000.00
0.00
D
Common Shares
1000.00
3000.00
I
By Spouse
No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
Each restricted share unit represents the contingent right to receive one common share of the Issuer.
The reporting person was granted 15,000 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date.
Not applicable.
The shares underlying this option vest in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service with the Issuer at each vesting date.
The reporting person was granted 13,000 restricted share units on January 7, 2022, vesting in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continued service with the Issuer at each vesting date.
The spouse of the reporting person was granted 4,000 restricted share units on January 7, 2022, vesting in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continued service with the Issuer at each vesting date.
Exhibit List: Exhibit 24: Power of attorney
/s/ George Clark, Attorney-in-Fact
2022-01-07
EX-24
2
estockpoa21.txt
POA2021
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby
constitutes and appoints each of Vlad Coric, Matthew Buten, George
Clark and Douglas Gray, or either of them signing singly, and with
full power of substitution, the undersigned's true and lawful
attorney-in-fact to:
(1) prepare, execute in the undersigned's name and on the
undersigned's behalf, and submit to the U.S. Securities and
Exchange Commission (the "SEC") any documents necessary or
appropriate to obtain codes and passwords enabling the
undersigned to make electronic filings with the SEC of
reports required by Section 16(a) of the Securities Exchange
Act of 1934 or any rule or regulation of the SEC;
(2) execute for and on behalf of the undersigned Forms 3, 4, and
5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934 and the rules thereunder;
(3) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete
and execute any such Form 3, 4, or 5, complete and execute
any amendment or amendments thereto, and timely file such
form with the SEC and any stock exchange or similar
authority; and
(4) take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit to, in the best interest
of, or legally required by, the undersigned, it being
understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to
this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing
whatsoever requisite, necessary, or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all
intents and purposes as the undersigned might or could do if
personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do
or cause to be done by virtue of this power of attorney and the rights
and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the
request of the undersigned, are not assuming, any of the undersigned's
responsibilities to comply with Section 16 of the Securities Exchange
Act of 1934.
This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 3, 4, and 5
with respect to the undersigned's holdings of and transactions in
securities issued by Biohaven Pharmaceutical Holding Company Ltd.,
unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 21st day of December, 2021.
/s/ Elyse Stock,
M.D.
Signature
Elyse Stock, M.D.
Print Name
\\\DC - 57385/2 - #1301253 v1
SC1:4975875.1
SC1:4975875.1